A simple, 10-mm immunoassay system has been developed that simultaneously screens for five different classes of drugs of abuse in a urine sample. This system tests for amphetamines, cannabinoids, cocaine metabolites, opiates, and phencyclidmne, and each assay has a specific preset cutoff concentration. 
three cases of nonspecific reactMty (at a drug concentration of 100 mg/L). Another panel of 12 compounds that could normally be found in urine samples was also evaluated and no interferences were observed. Concordance was >95% between this system and the comparable automated immunoassays for detecting drugs of abuse. 
Greater than 98% of GC/MS

Materials and Methods
DisposableSystem
The Advisor reaction disc has been designed as a self-performing unit, which allows multiple agglutination assays to occur within a laminated test card ( Figure   2) . A central well serves as the entrance site for the mixture of test sample and reagents. Liquid flowing into this well is diverted into seven radial channels that have absorbent paper strips located at their outermost sections. These paper strips serve as blotters, maintaining a very slow flow of liquid through the channels over the course of several minutes. The size (shape and thickness) of these paper strips has been optimized to control 
Drug Standards and Samples
Drug standards for reproducibility testing were prepared by dissolving drug analytes at specified concentrations in drug-free human urine containing dimethyl sulfoxide, 100 milL. 
11-nor-delta-9-
tetrahydrocannabinol-9-carboxylic acid, benzoylecgonine, morphine, and PCP. Urine samples were collected and frozen at -20 #{176}C. Before analysis all samples were completely thawed and mixed. TDx analyses of the urine samples were performed with the same reagent kits mentioned above.
Gas chromatography/mass spectrometry (GCIMS) analyses were performed at a commercial reference laboratory (Aegis Analytical Laboratories Inc., Nashville, Each assay has a unique preset cutoff concentration, above which positive results will be obtained.
This immunoassay configuration provides a very steep transition between positive and negative reactions.
As seen in Figure 3 , very strong agglutination reactions will occur for each of the drug channels when sample containing one-half the cutoff concentration of drug is used. Accuracy was >99% for samples containing drug concentrations representing one-half the cutoff value for each assay (lowest concentration on chart for each assay). Also, positive results were obtained with >99% accuracy for samples containing drug at twice the cutoff with all five drug assays.
Cross-reactivity.
A large panel of drugs or other potentially interfering compounds (Table 2 ) was evaluated for cross-reactivity with the Advisor assays. Samples of each drug were prepared in drug-free human urine at concentrations of 100 mgIL or greater and aliquots were assayed to determine undesirable cross-reactivity. All but three compounds showed no reactivity with any of the assays at the concentrations tested. Phenethylamine at 100 mg/L produced a positive reaction for the amphetamine assay, but no cross-reactivity Interferences. Several compounds that ordinarily could be present in a urine specimen were evaluated for nonspecific interference in the Advisor assays.
Compounds were dissolved in normal human urine at the concentrations listed in Table 3 . We then added to these urine samples enough concentrated drug solution to As the results show ( 
